Home
½ÃÀÛÆäÀÌÁö
Áö³È£º¸±â
·Î±×ÀÎ
ȸ¿ø°¡ÀÔ
±¸µ¶½Åû
Àüü±â»ç
2024-03-29 ±Ý 19:31
±â»ç°Ë»ö
Cover Story
¼øȯ±â
³»ºÐºñ
È£Èí±â
¼Òȱâ
½Å°æ°ú
Á¤½Å°Ç°
°¨¿°³»°ú
Sub Story
Interview
Drug Review
Conference Report
Late Breaking Studies
Expert Opinion
Primary Expert Opinion
The Rare Disease
ÇмúÀÚ¹®À§¿ø
RTM
»ó´Ü¿©¹é
񃯇
(Àüü 127°Ç)
Á¦¸ñº¸±â
Á¦¸ñº¸±â
Á¦¸ñ+³»¿ë
[Sub Story]
´ç´¢º´ ȯÀÚ Ç×°íÇ÷¾ÐÁ¦ º´¿ë 150/90mmHg ÀÌ»óºÎÅÍ
ÀÌ»óµ· ±âÀÚ
2024-02-07 15:43
[Cover Story]
Çѱ¹ÀÎ ³úÁ¹Áß, ¼¾ç°ú À¯º´Æ¯¼º ´Ù¸£´Ù
ÀÌ»óµ· ±âÀÚ
2023-07-05 16:49
[Sub Story]
¡°ICAS¡¤¼ÒÇ÷°üÁúȯ¡¤ÃâÇ÷¿¡ ÁÖ¸ñÇؾߡ±
ÀÌ»óµ· ±âÀÚ
2023-07-05 16:43
[Sub Story]
[2022 ´ëÇѺÎÁ¤¸ÆÇÐȸ ½É¹æ¼¼µ¿ ȯÀÚ¿¡¼ NOAC »ç¿ëÁöħ]
¿ÍÆĸ° Åõ¿© ¾Æ½Ã¾ÆÀο¡¼ ³ú°æ»ö ¿¹¹æ î¸, ³úÃâÇ÷ À§Çè ÍÔ
ÀÌ»óµ· ±âÀÚ
2023-07-05 16:31
[Interview]
³úÁ¹Áß¡¤½É¹æ¼¼µ¿ µ¿¹Ý½Ã ±Þ¼º±â °æ±¸Ç×ÀÀ°íÄ¡·á¿¡ NOAC ÇýÅáè
ÀÌ»óµ· ±âÀÚ
2023-07-05 16:26
¶óÀÎ
[Sub Story]
°ü»óµ¿¸ÆÁúȯ ȯÀÚ¿¡°Ô NOACÀ̶õ?
ÀÌ»óµ· ±âÀÚ
2023-07-05 16:02
[Sub Story]
DAPT+NOAC, ÃâÇ÷À§ÇèÀº ¾î¼³ª?
ÀÌ»óµ· ±âÀÚ
2023-07-05 15:31
[Drug Review]
PAD Àç°ü·ù¼ú ÈÄ ¡®»ç¸£Æ÷±×·¼·¹ÀÌÆ® + ¾Æ½ºÇǸ°¡¯ DAPT ±Ù°Å È®º¸
ÀÓ¼¼Çü ±âÀÚ
2023-07-05 15:26
[Conference Report]
ÇãÇ÷¼º ³úÁ¹Áß¿¡ ´ëÇÑ NOAC È¿°ú È®ÀÎ
ÀÓ¼¼Çü ±âÀÚ
2023-03-10 13:45
[Sub Story]
Ç÷´ç¡¤Ç÷¾Ð¡¤ÁöÁúÁ¶Àý ¸ñÀûÀº ½ÉÇ÷°üÁúȯ ¿¹¹æ
ÀÌ»óµ· ±âÀÚ
2023-02-07 10:36
¶óÀÎ
[Late Breaking Studies]
PPI, À§¾Ï °ü·Ã ¾ÈÀü¼º È®ÀÎ
ÀÓ¼¼Çü ±âÀÚ
2023-01-06 18:10
[Sub Story]
NOAC ³úÁ¹Áß ¿¹¹æÇýÅà £¾ ÃâÇ÷À§Çè
ÀÓ¼¼Çü ±âÀÚ
2022-12-06 10:58
[Deep in Guideline]
SGLT-2¾ïÁ¦Á¦ ½ÉºÎÀü Ä¡·áÁ¦·Î Àü¸é¿¡
ÀÓ¼¼Çü ±âÀÚ
2022-12-06 10:44
[Primary Expert Opinion]
[1Â÷ ÀÇ·á±â°ü ½ÃÁ¡ÀÇ ½É¹æ¼¼µ¿ °ü¸®Àü·«]
¡°ÀÌÁ¦´Â 1Â÷ÀÇ·á¿¡¼ Àû±ØÀûÀ¸·Î ½É¹æ¼¼µ¿À» °ü¸®ÇØ¾ß ÇÑ´Ù¡±
THE MOST
2022-12-05 15:55
[Sub Story]
³úÁ¹Áß¡¤ÃâÇ÷ °¨¼Ò À§ÇÑ Ç×ÀÀ°í¡¤Ç×°íÇ÷¾Ð Ä¡·á ÇÊ¿ä
ÀÓ¼¼Çü ±âÀÚ
2022-10-06 14:26
¶óÀÎ
[Sub Story]
[À¯·´½Å°æ°úÇÐȸ Ä¡¸Å °ü¸®À̽´ °¡À̵å¶óÀÎ 2022]
Ä¡¸Å¿¹¹æ¿¡ Ç÷°ü¼º À§ÇèÀÎÀÚ ÁÖ¸ñ
ÀÓ¼¼Çü ±âÀÚ
2022-09-05 15:43
[Conference Report]
NOAC ÇãÇ÷¼º ³úÁ¹Áß ¿µ¿ª¿¡ ÀÚ¸®Àâ´Ù
ÀÓ¼¼Çü ±âÀÚ
2022-03-08 15:44
[Sub Story]
Ç÷´ç¡¤ÄÝ·¹½ºÅ×·Ñ¡¤Ç÷¾ÐÁ¶Àý ÇÕÃÄ¾ß ½ÉÇ÷°üÁúȯ ¿¹¹æ
ÀÌ»óµ· ±âÀÚ
2022-02-07 17:00
[Conference Report]
TAVI ÈÄ NOAC Ä¡·á ¡®Àý¹ÝÀÇ ¼º°ø¡¯
THE MOST
2021-10-05 11:11
[Interview]
ÇÁ¶ó¼ö±×·¼, ±Ù°Å ÅëÇØ ÀÓ»óÇöÀå ¾ÈÀü¼º ÇÁ·ÎÆÄÀÏ, Æí¸®¼º ¸ðµÎ È®º¸
ÀÓ¼¼Çü ±âÀÚ
2021-08-09 16:17
-
1
2
3
4
5
6
7
-
¿©¹é
Sub
news
¡°ACEI ÀÓ»ó±Ù°Å ³õ°í, ȯÀÚ ¼³µæÇÏÀÚ¡±
Q. Ç÷¾Ð°ÇÏ Ãø¸é¿¡¼ ACEIÀÇ Æ¯¼ºÀº?ù...
¡°SGLT-2i Ȳ±Ý±â´Â TZD¿Í º´¿ëÀ¸·ÎºÎÅÍ¡±
Q. SGLT-2iÀÇ °è¿È¿°ú¿¡ ´ëÇÑ °ßÇØ´Â...
¡°°í°µµ ½ºÅ¸Æ¾ Á¦Á¦ È¿°ú ´ëµîÇϳª ¾ÈÀü¼º ´Ù¸¦ ¼öµµ¡±
Q. CAD ȯÀÚÀÇ ÀÌ»óÁöÁúÇ÷Áõ Ä¡·áÀü·«Àº?...
¿©¹é
¿©¹é
Back to Top